
|Videos|October 17, 2017
I Never Stopped Being Mom
Advertisement
Episodes in this series

Advertisement
Related to this article

Learn how nipple-sparing mastectomy, including endoscopic approaches, may help preserve appearance, reduce scarring and support breast cancer recovery.

After 17 and a half years with metastatic primary peritoneal cancer, a former hospital executive explains how an AI health agent helped her after discharge.

Giredestrant plus Afinitor lowered the risk of cancer worsening or death by 62% in patients with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer.

A study of more than 17,000 patients ages 23 to 64, presented at ASTRO 2026, found that only about 28% took endocrine therapy consistently for five years, and people who skipped radiation were more likely to fall off. Here's what to weigh before making that choice.

September brought new options for breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus a brain tumor scan and easier lung cancer treatment.

Breast cancer treatment has changed dramatically since 2021. Here are the key FDA approvals, year by year, and what they mean for patients.

Sue Weldon, a 22-year breast cancer survivor and Unite for HER founder, explains how integrative therapies helped her heal after chemotherapy.
Advertisement
Advertisement
Trending on CURE
1
Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free
2
Phase 3 Trial Shows Adding Imdelltra to First-Line Treatment Helps Patients With SCLC Live Longer
3
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
4
10 Cancer Treatment Approvals From September 2026 and What They Mean for You
5









